Picture of Hikma Pharmaceuticals logo

HIK — Hikma Pharmaceuticals News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Brief: Hikma Launches Glucentra As First Generic Semaglutide Available To Patients In Saudi Arabia

BRIEF-Hikma Launches Glucentra As First Generic Semaglutide Available To Patients In Saudi Arabia

- Hikma Pharmaceuticals PLC HIK.L:

  • HIKMA: LAUNCHES GLUCENTRA AS THE FIRST GENERIC SEMAGLUTIDE AVAILABLE TO PATIENTS IN SAUDI ARABIA

Further company coverage: HIK.L


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Hikma Pharmaceuticals

See all news